HIGHLIGHTS • Left ventricular stroke work index (LVSWi) and right ventricular stroke work index (RVSWi) independently predict mortality after transcatheter mitral valve repair (TMVR). • Patients with low LVSWi and…
The aim of this study was to assess differences in etiology, comorbidities, echocardiographic parameters, and prognosis between men and women with significant tricuspid regurgitation (TR). Clinical and echocardiographic characteristics of…
Breast cancer and cardiovascular-specific mortality are higher among blacks compared with whites, but disparities in cancer therapy-related adverse cardiovascular outcomes have not been well studied. We assessed for the contribution…
Highlights • Long-term data for patients undergoing TAVI with the first generation self-expanding bioprosthesis are consistent with low mortality rates and satisfying valve performance. • Really long-term clinical outcomes and…
There are limited data to support proposed increases to the minimum institutional mitral valve (MV) surgery volume required to begin a transcatheter mitral valve repair (TMVr) program. The current study…
• Thromboembolic events remain clinically resolved after TAVR. • DOAC use to reduce thrombosis associated with TAVR remains controversial. • Coagulation parameters were significantly increased after TAVR. • Hypercoagulation status…
HIGHLIGHTS • Prompt initiation of diuretic therapy was not correlated with faster decongestion in acute heart failure. • The timing of decongestion but not diuretics was associated with better biomarker…
Highlights • NT-proBNP testing increases diagnostic accuracy in dyspneic patients suspected of acute heart failure. • False negatives may be discharged from emergency department (ED), and undergo costly readmissions later….
HIGHLIGHTS • The rate of cardiac rhythm monitoring at 6 months after stroke is just over one-third. • Only 30% of patients with cryptogenic strokes receive implantable loop recorders. •…
Effect of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) among hypertensive patients with coronavirus disease 2019 (COVID-19) is debated. The aim of the COVIDECA study was to…
